Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock.
Acute kidney disease
Acute kidney injury
Disseminated intravascular coagulation
Sepsis
Septic shock
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
23
08
2023
accepted:
17
11
2023
medline:
1
12
2023
pubmed:
1
12
2023
entrez:
1
12
2023
Statut:
epublish
Résumé
Disseminated intravascular coagulation (DIC) worsens the prognosis of septic shock and contributes to multiple organ failure. To date, no data linking DIC and acute kidney injury (AKI) occurrence, severity, and evolution in this setting are available. We aimed at analyzing the association between AKI occurrence, severity and evolution in patients with septic shock-induced DIC. In a prospective monocentric cohort study, consecutive patients, 18 years and older, admitted in the ICU of Strasbourg University Hospital in the setting of systemic hypotension requiring vasopressor related to an infection, without history of terminal chronic kidney disease were eligible. AKI was defined according to the KDIGO classification. DIC diagnosis was based on the International Society on Thrombosis and Haemostasis (ISTH) score. Evolution of AKI was evaluated through the composite endpoint of major adverse kidney events. Only patients with DIC that occurred before or at the time of AKI diagnosis were considered. Univariate and multivariate analysis were performed to determine factors associated with renal outcomes. 350 patients were included, of whom 129 experienced DIC. Patients with DIC were more seriously ill (median SAPS II 64 vs. 56, p < 0.001), and had higher 28-day mortality (43.3% vs. 26.2%, p < 0.001). AKI was more frequent in patients with DIC (86.8% vs. 74.2%, p < 0.005), particularly for the more severe stage of AKI [KDIGO 3 in 58.1% of patients with DIC vs. 30.8% of patients without DIC, p < 0.001, AKI requiring renal replacement therapy (RRT) in 47.3% of patients with DIC vs. 21.3% of patients without DIC, p < 0.001]. After adjustment for confounding factors, DIC occurrence remained associated with the risk of having the more severe stage of AKI with an odds ratio (OR) of 2.74 [IC 95% (1.53-4.91), p < 0.001], and with the risk of requiring RRT during the ICU stay [OR 2.82 (1.53-5.2), p < 0.001]. DIC appears to be strongly associated with the risk of developing the more severe form of AKI (stage 3 of the KDIGO classification, RRT requirement), even after adjustment for severity and other relevant factors.
Sections du résumé
BACKGROUND
BACKGROUND
Disseminated intravascular coagulation (DIC) worsens the prognosis of septic shock and contributes to multiple organ failure. To date, no data linking DIC and acute kidney injury (AKI) occurrence, severity, and evolution in this setting are available. We aimed at analyzing the association between AKI occurrence, severity and evolution in patients with septic shock-induced DIC. In a prospective monocentric cohort study, consecutive patients, 18 years and older, admitted in the ICU of Strasbourg University Hospital in the setting of systemic hypotension requiring vasopressor related to an infection, without history of terminal chronic kidney disease were eligible. AKI was defined according to the KDIGO classification. DIC diagnosis was based on the International Society on Thrombosis and Haemostasis (ISTH) score. Evolution of AKI was evaluated through the composite endpoint of major adverse kidney events. Only patients with DIC that occurred before or at the time of AKI diagnosis were considered. Univariate and multivariate analysis were performed to determine factors associated with renal outcomes.
RESULTS
RESULTS
350 patients were included, of whom 129 experienced DIC. Patients with DIC were more seriously ill (median SAPS II 64 vs. 56, p < 0.001), and had higher 28-day mortality (43.3% vs. 26.2%, p < 0.001). AKI was more frequent in patients with DIC (86.8% vs. 74.2%, p < 0.005), particularly for the more severe stage of AKI [KDIGO 3 in 58.1% of patients with DIC vs. 30.8% of patients without DIC, p < 0.001, AKI requiring renal replacement therapy (RRT) in 47.3% of patients with DIC vs. 21.3% of patients without DIC, p < 0.001]. After adjustment for confounding factors, DIC occurrence remained associated with the risk of having the more severe stage of AKI with an odds ratio (OR) of 2.74 [IC 95% (1.53-4.91), p < 0.001], and with the risk of requiring RRT during the ICU stay [OR 2.82 (1.53-5.2), p < 0.001].
CONCLUSION
CONCLUSIONS
DIC appears to be strongly associated with the risk of developing the more severe form of AKI (stage 3 of the KDIGO classification, RRT requirement), even after adjustment for severity and other relevant factors.
Identifiants
pubmed: 38038826
doi: 10.1186/s13613-023-01216-8
pii: 10.1186/s13613-023-01216-8
pmc: PMC10692023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
119Informations de copyright
© 2023. The Author(s).
Références
Intensive Care Med. 2023 Mar;49(3):273-290
pubmed: 36808215
Shock. 2014 Jan;41(1):3-11
pubmed: 24346647
Thromb Res. 2019 Jun;178:182-188
pubmed: 31054468
J Infect. 2016 Feb;72(2):131-42
pubmed: 26702738
Intensive Care Med. 2010 Mar;36(3):471-8
pubmed: 19924395
Chest. 1992 Mar;101(3):816-23
pubmed: 1531791
Am J Physiol Renal Physiol. 2007 Jan;292(1):F261-8
pubmed: 16926442
Crit Care. 2003 Apr;7(2):130-8
pubmed: 12720559
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Thromb Haemost. 2004 Nov;2(11):1924-33
pubmed: 15550023
N Engl J Med. 2004 Jul 8;351(2):159-69
pubmed: 15247356
Intensive Care Med. 2023 Sep;49(9):1079-1089
pubmed: 37432520
Ann Intensive Care. 2019 Sep 23;9(1):106
pubmed: 31549274
Clin J Am Soc Nephrol. 2012 May;7(5):844-50
pubmed: 22442182
Am J Physiol Renal Physiol. 2005 Dec;289(6):F1324-32
pubmed: 15998845
JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Infect Drug Resist. 2019 Sep 04;12:2755-2764
pubmed: 31564926
J Thromb Haemost. 2019 Aug;17(8):1265-1268
pubmed: 31099127
Am J Hematol. 2004 Jul;76(3):225-9
pubmed: 15224356
Intensive Care Med. 2009 May;35(5):871-81
pubmed: 19066848
Thromb Haemost. 2001 Nov;86(5):1327-30
pubmed: 11816725
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
FASEB J. 2019 Dec;33(12):14270-14280
pubmed: 31682515
Crit Care. 2017 Aug 25;21(1):229
pubmed: 28841902
Thromb J. 2017 Jul 3;15:17
pubmed: 28680365
Acute Med Surg. 2019 Apr 01;6(3):223-232
pubmed: 31304023
J Clin Pathol. 2010 Nov;63(11):1021-6
pubmed: 20870661
J Am Soc Nephrol. 2003 Mar;14(3):792-805
pubmed: 12595518
Nephrol Dial Transplant. 2012 Dec;27(12):4263-72
pubmed: 23045432
J Am Soc Nephrol. 2014 Mar;25(3):595-605
pubmed: 24503241
Nat Rev Nephrol. 2016 Feb;12(2):94-109
pubmed: 26592189
Semin Thromb Hemost. 2022 Nov;48(8):978-987
pubmed: 36100234
Kidney Int. 2019 Nov;96(5):1083-1099
pubmed: 31443997
Crit Care Med. 2016 Oct;44(10):e930-9
pubmed: 27322364
Am J Respir Crit Care Med. 2016 Feb 1;193(3):281-7
pubmed: 26398704
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
Intensive Care Med. 2013 Oct;39(10):1695-703
pubmed: 23793890
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Ann Intensive Care. 2017 Dec 2;7(1):117
pubmed: 29197958
Crit Care. 2016 Sep 14;20:287
pubmed: 27629997
J Invest Surg. 2019 Dec;32(8):689-696
pubmed: 29693474
Intensive Care Med. 2017 Jun;43(6):816-828
pubmed: 28364303
Crit Care Med. 2002 Sep;30(9):2051-8
pubmed: 12352040